A new COVID vaccine will now be available in the U.S. after health officials recommended it Tuesday.
In contrast, the Novavax vaccine injects copies of the spike protein that are grown in a lab and packaged into nanoparticles that to the immune system resemble a virus. Another difference: An ingredient called an adjuvant, that’s made from the bark of a South American tree, is added to help rev up that immune response.
“We really need to focus on that population,” said CDC adviser Dr. Oliver Brooks, past president of the National Medical Association. Hopefully, the vaccine"will change them over from being unvaccinated to vaccinated.” Typical vaccine reactions were mild, including arm pain and fatigue, but regulators did warn about the possibility of a rare risk, heart inflammation, that also has been seen with the Pfizer and Moderna vaccines, mostly in teen boys or young men.
According to the company,"serious and severe adverse events were low in number and balanced between vaccine and placebo groups" during clinical trials.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
CDC panel endorses new Novavax COVID vaccineAdvisors to the Centers for Disease Control and Prevention voted Tuesday to endorse emergency authorization of a new COVID-19 vaccine developed by the Maryland biotechnology company Novavax, making it the fourth immunization to clear that hurdle in the U.S. — and the first to rely on the same familiar technology as some seasonal flu shots.
Read more »
CDC advisory panel votes to recommend the Novavax Covid vaccineA green light from the CDC will pave the way for 3.2 million doses of the Novavax vaccine to be distributed in the United States.
Read more »
CDC endorses more traditional Novavax COVID-19 vaccine for adultsHealth officials say U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax.
Read more »
CDC recommends Novavax Covid vaccineBREAKING: CDC recommends Novavax's two-dose Covid vaccine for adults, giving Americans another option to protect against the virus.
Read more »
CDC endorses more traditional Novavax COVID-19 vaccine for adultsHealth officials say U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax.
Read more »
CDC advisory panel votes to recommend the Novavax COVID-19 vaccineA green light from the CDC will pave the way for 3.2 million doses of the Novavax vaccine to be distributed in the United States.
Read more »